Your browser doesn't support javascript.
loading
Emerging noninvasive methylation biomarkers of cancer prognosis and drug response prediction.
Oliver, Javier; Garcia-Aranda, Marilina; Chaves, Patricia; Alba, Emilio; Cobo-Dols, Manuel; Onieva, Juan Luis; Barragan, Isabel.
Afiliação
  • Oliver J; Instituto de Investigación Biomédica de Málaga - IBIMA; Medical Oncology Service, Section of Immuno-Oncology, Hospitales Universitarios Regional y Virgen de la Victoria; C/ Marqués de Beccaría n°3, 29010, Málaga, Spain. Electronic address: javier.oliver@ibima.eu.
  • Garcia-Aranda M; Instituto de Investigación Biomédica de Málaga - IBIMA; Research Unit. Hospital Costa del Sol. Research Network on Health Services in Chronic Diseases (REDISSEC). Autovía A-7, km 187, 29603 Marbella, Málaga, Spain; Surgery, Biochemistry and Immunology Department. Medical School, University of Málaga
  • Chaves P; Instituto de Investigación Biomédica de Málaga - IBIMA; Medical Oncology Service, Section of Immuno-Oncology, Hospitales Universitarios Regional y Virgen de la Victoria; C/ Marqués de Beccaría n°3, 29010, Málaga, Spain; University of Málaga, Spain. Electronic address: pchaves@uma.es.
  • Alba E; Instituto de Investigación Biomédica de Málaga - IBIMA; Medical Oncology Service, Hospitales Universitarios Regional y Virgen de la Victoria; Department of Medicine and Dermatology, University of Málaga; C/ Marqués de Beccaría n°3, 29010, Málaga, Spain. Electronic address: ealbac@uma.es.
  • Cobo-Dols M; Instituto de Investigación Biomédica de Málaga - IBIMA; Medical Oncology Service, Section of Immuno-Oncology, Hospitales Universitarios Regional y Virgen de la Victoria; C/ Marqués de Beccaría n°3, 29010, Málaga, Spain. Electronic address: mangel.cobo.sspa@juntadeandalucia.es.
  • Onieva JL; Instituto de Investigación Biomédica de Málaga - IBIMA; Medical Oncology Service, Section of Immuno-Oncology, Hospitales Universitarios Regional y Virgen de la Victoria; C/ Marqués de Beccaría n°3, 29010, Málaga, Spain. Electronic address: juan.luis.onieva@ibima.eu.
  • Barragan I; Instituto de Investigación Biomédica de Málaga - IBIMA; Medical Oncology Service, Section of Immuno-Oncology, Hospitales Universitarios Regional y Virgen de la Victoria; C/ Marqués de Beccaría n°3, 29010, Málaga, Spain; Group of Pharmacoepigenetics, Department of Physiology and Pharmacology, Karolin
Semin Cancer Biol ; 83: 584-595, 2022 08.
Article em En | MEDLINE | ID: mdl-33757849
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácidos Nucleicos Livres / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Semin Cancer Biol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácidos Nucleicos Livres / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Semin Cancer Biol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article